Abstract
l-Arginine hydrochloride (Arg HCl) has been used for protein refolding as a universal aggregation suppressor for monomeric proteins. This paper presents an investigation of the refolding of tetrameric beta-galactosidase (β-gal) using Arg HCl and other salts. In a binary system using only Arg HCl, the refolding yield of β-gal increased with increasing concentration up to 0.2 M. However, the refolding yield sharply decreased above this concentration, reaching the level below the control yield of 5% at 0.5 M and near zero above 0.75 M, an observation unexpected from monomeric proteins. In a ternary system using both 0.2 M Arg HCl and another salt, the refolding yield increased up to 1.5-fold higher than that in the binary system. These data indicate that aggregation suppressive effects of protein increase with Arg HCl concentration, but also are deleterious to self-association of the protein. This dual nature of Arg HCl effects may have to be taken into account in its application for refolding of oligomeric proteins.
Similar content being viewed by others
Abbreviations
- Arg HCl:
-
l-Arginine hydrochloride
- β-gal:
-
Beta-galactosidase
- DTT:
-
Dithiothreitol
- EDTA:
-
Ethylenediaminetetraacetic acid
- Gdn HCl:
-
Guanidine hydrochloride
- Tween 20:
-
Polyoxyethylene sorbitan monolaurate
- Na3-citrate:
-
Trisodium citrate
- Tris-HCl:
-
Tris(hydroxymethyl)aminomethane hydrochloride
- ONPG:
-
o-Nitrophenyl-β-d-galactopyranoside
References
Arakawa T, Ejima D, Tsumoto K, Obeyama N, Tanaka Y, Kita Y, Timasheff SN (2007) Biophys Chem 127:1–8
Arakawa T, Tsumoto K (2003) Biochem Biophys Res Commun 304:148–152
Asano R, Kudo T, Makabe K, Tsumoto K, Kumagai I (2002) FEBS Lett 528:70–76
Ayling A, Baneyx F (1996) Protein Sci 5:478–487
Bachhawat K, Kapoor M, Dam TK, Surolia A (2001) Biochemistry 40:7291–7300
Baldwin RL (1996) Biophys J 71:2056–2063
Baynes BM, Trout BL (2004) Biophys J 87:1631–1639
Baynes BM, Wang DI, Trout BL (2005) Biochemistry 44:4919–4925
Brinkmann U, Buchner J, Pastan I (1992) Proc Natl Acad Sci USA 89:3075–3079
Buchner J, Rudolph R (1991) Biotechnology (NY) 9:157–162
Charles JE, Robert FG (1963) J Biol Chem 283:1380–1383
Chi EY, Krishnan S, Randolph TW, Carpenter JF (2003) Pharm Res 20:1325–1336
Dev S, ND K, Sinha S, Surolia A (2006) IUBMB Life 58:549–555
Fischer BE (1994) Biotechnol Adv 12:89–101
Fitter J (2009) Cell Mol Life Sci 66:1672–1681
Freeman BC, Morimoto RI (1996) EMBO J 15:2969–2979
Gao YG, Guan YX, Yao SJ, Cho MG (2003) Biotechnol Prog 19:915–920
Hamada H, Arakawa T, Shiraki K (2009) Curr Pharm Biotechnol 10:400–407
He J, Wang G, Xu R, Feng J, Wang J, Su H, Song H (2008) Appl Biochem Biotechnol 151:29–41
Hirano A, Arakawa T, Shiraki K (2008) J Biochem 144:363–369
Hirano A, Hamada H, Okubo T, Noguchi T, Higashibata H, Shiraki K (2007) Protein J 26:423–433
Jacobson RH, Zhang XJ, DuBose RF, Matthews BW (1994) Nature 369:761–766
Kamna J, Arshad J, Debendra KS (2008) Process Biochem 43:587–597
Li M, Su ZG, Janson JC (2004) Protein Exp Purif 33:1–10
Li S, Bai JH, Park YD, Zhou HM (2001) Int J Biochem Cell Biol 33:279–286
Lin WJ, Traugh JA (1993) Protein Exp Purif 4:256–264
Melander W, Horvath C (1977) Arch Biochem Biophys 183:200–215
Mishra R, Seckler R, Bhat R (2005) J Biol Chem 280:15553–15560
Neet KE, Timm DE (1994) Protein Sci 3:2167–2174
O’Brien EP, Dima RI, Brooks B, Thirumalai D (2007) J Am Chem Soc 129:7346–7353
Oneda H, Inouye K (1999) J Biochem 126:905–911
Rattenholl A, Lilie H, Grossmann A, Stern A, Schwarz E, Rudolph R (2001) Eur J Biochem 268:3296–3303
Reddy KRC, Lilie H, Rudolph R, Lange C (2005) Protein Sci 14:929–935
Rudolph R, Lilie H (1996) FASEB J 10:49–56
Shiraki K, Kudou M, Fujiwara S, Imanaka T, Takagi M (2002) J Biochem 132:591–595
Stoyan T, Michaelis U, Schooltink H, Van Dam M, Rudolph R, Heinrich PC, Rose-John S (1993) Eur J Biochem 216:239–245
Suenaga M, Ohmae H, Tsuji S, Itoh T, Nishimura O (1998) Biotechnol Appl Biochem 28:119–124
Tanaka N, Nakao S, Wadai H, Ikeda S, Chatellier J, Kunugi S (2002) Proc Natl Acad Sci USA 99:15398–15403
Taneja S, Ahmad F (1994) Biochem J 303:147–153
Togashi H, Nara T, Sekikawa C, Kawakami M, Yaginuma N, Tsunoda T, Sakaguchi K, Mizukami F (2009) Biotechnol Prog 25:200–206
Tsumoto K, Ejima D, Kumagai I, Arakawa T (2003) Protein Exp Purif 28:1–8
Tsumoto K, Shinoki K, Kondo H, Uchikawa M, Juji T, Kumagai I (1998) J Immunol Methods 219:119–129
Tsumoto K, Umetsu M, Kumagai I, Ejima D, Philo JS, Arakawa T (2004) Biotechnol Prog 20:1301–1308
Umetsu M, Tsumoto K, Hara M, Ashish K, Goda S, Adschiri T, Kumagai I (2003) J Biol Chem 278:8979–8987
Wang XT, Engel PC (2009) BMC Biotechnol 9:19
Yin FY, Chen YH, Yu CM, Pon YC, Lee HJ (2007) Biophys J 93:1235–1245
Zhi W, Landry SJ, Gierasch LM, Srere PA (1992) Protein Sci 1:522–529
Acknowledgments
This work was partly supported by the Tsukuba Industrial Liaison and Cooperative Research Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fujimoto, A., Hirano, A. & Shiraki, K. Ternary System of Solution Additives with Arginine and Salt for Refolding of Beta-Galactosidase. Protein J 29, 161–166 (2010). https://doi.org/10.1007/s10930-010-9235-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-010-9235-7